Do you know someone with Chronic spontaneous urticaria (CSU) ?

They may be eligible for a study and receive compensation for time and travel

Sign up here or contact us and our research coordinator will be in touch for screening. 

Call for Participants
With Chronic spontaneous urticaria (CSU):

Clinical Study 2025-2026
(18+ years old) 

A study to evaluate a new Chronic spontaneous urticaria (CSU) treatment in adults is open for enrollment. Study-related procedures and study medication are covered at no cost to you. Participants who qualify will be compensated for time and reasonable expenses for their visits. It is a great opportunity to receive close care by doctors you trust. Space limited! Sign up to see if you are qualified.

Read more about this study on Clinicaltrial.gov: https://clinicaltrials.gov/study/NCT06832618
What is Chronic spontaneous urticaria (CSU)? Read about different kinds of hives on our Hives page.

Read our resources (including FAQs and Interview): https://asthma2.com/category/hives/

Minimum Eligibility Requirements:

– Be at least 18 years old and diagnosed with Chronic Hives (Chronic Spontaneous Urticaria)

– Taking/took anti-histamine regularly for the condition

Study Details:

– Researchers are studying a new AD/Eczema cream treatment (phase 3), taking place at the center in Normal, IL. Participants will be compensated for reasonable travel expenses.

If you meet these requirements, please sign up in our interest form. Our clinical trial staff will contact you for screening.

Contact us for more information, SWIA Clinical Research Dept.: Stephanie 309-451-7509 or Abby 309-503-5576. Or email us at research@asthma2.com

______________________________

Why participate in clinical research? All of the medicines you currently take for your health were first studied in clinical trials before the FDA approved them.  It is a great way to help your community, while getting close care and monitoring by doctors you know.

See other active clinical trials here.

Page updated: Aug 2025